Commentary on “DAB389IL-2 (ONTAK): A Novel Fusion Toxin Therapy for Lymphoma”
LeMaistre, Charles F.Volume:
1
Language:
english
Journal:
Clinical Lymphoma
DOI:
10.1016/s1526-9655(11)70209-3
Date:
September, 2000
File:
PDF, 38 KB
english, 2000